219 related articles for article (PubMed ID: 9512107)
41. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M
Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
[TBL] [Abstract][Full Text] [Related]
42. Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients.
Poormoghim H; Lucas M; Fertig N; Medsger TA
Arthritis Rheum; 2000 Feb; 43(2):444-51. PubMed ID: 10693887
[TBL] [Abstract][Full Text] [Related]
43. Pulmonary hypertension in the CREST syndrome: variant of systemic sclerosis (scleroderma)--a case report.
Lie JT
Angiology; 1989 Aug; 40(8):764-7. PubMed ID: 2757266
[TBL] [Abstract][Full Text] [Related]
44. Systemic sclerosis (scleroderma). Clinical management of its major complications.
Legerton CW; Smith EA; Silver RM
Rheum Dis Clin North Am; 1995 Feb; 21(1):203-16. PubMed ID: 7732169
[TBL] [Abstract][Full Text] [Related]
45. Systemic sclerosis sine scleroderma associated with Wolff-Parkinson-White syndrome.
Park YW; Woo H; Yoon HJ; Park HW; Cho JG; Shin SS; Lee SS
Scand J Rheumatol; 2007; 36(1):68-70. PubMed ID: 17454939
[TBL] [Abstract][Full Text] [Related]
46. [Hand involvement in systemic sclerosis].
Mouthon L
Presse Med; 2013 Dec; 42(12):1616-26. PubMed ID: 24268960
[TBL] [Abstract][Full Text] [Related]
47. CXCL13 produced by macrophages due to Fli1 deficiency may contribute to the development of tissue fibrosis, vasculopathy and immune activation in systemic sclerosis.
Taniguchi T; Miyagawa T; Toyama S; Yamashita T; Nakamura K; Saigusa R; Ichimura Y; Takahashi T; Toyama T; Yoshizaki A; Sato S; Asano Y
Exp Dermatol; 2018 Sep; 27(9):1030-1037. PubMed ID: 29947047
[TBL] [Abstract][Full Text] [Related]
48. Unilateral limited scleroderma-like changes following formation of an arteriovenous fistula.
Roberts H; Curnow PA
Australas J Dermatol; 2007 Feb; 48(1):37-9. PubMed ID: 17222301
[TBL] [Abstract][Full Text] [Related]
49. Evolution of primary Raynaud's phenomenon (Raynaud's disease) to connective tissue disease.
Gerbracht DD; Steen VD; Ziegler GL; Medsger TA; Rodnan GP
Arthritis Rheum; 1985 Jan; 28(1):87-92. PubMed ID: 3871330
[TBL] [Abstract][Full Text] [Related]
50. Systemic sclerosis in Sarawak: a profile of patients treated in the Sarawak General Hospital.
Teh CL; Kuan YC; Wong JS
Rheumatol Int; 2009 Aug; 29(10):1243-5. PubMed ID: 19373465
[TBL] [Abstract][Full Text] [Related]
51. Progressive systemic sclerosis sine scleroderma presenting as pulmonary interstitial fibrosis.
Lomeo RM; Cornella RJ; Schabel SI; Silver RM
Am J Med; 1989 Nov; 87(5):525-7. PubMed ID: 2683765
[TBL] [Abstract][Full Text] [Related]
52. [Systemic sclerosis].
Peltomaa R; Pettersson T; Tuompo R; Luosujärvi R
Duodecim; 2013; 129(19):1981-91. PubMed ID: 24218729
[TBL] [Abstract][Full Text] [Related]
53. Systemic sclerosis: Current concepts of skin and systemic manifestations.
Pearson DR; Werth VP; Pappas-Taffer L
Clin Dermatol; 2018; 36(4):459-474. PubMed ID: 30047430
[TBL] [Abstract][Full Text] [Related]
54. [Progressive systemic scleroderma--prognosis determining involvement of internal organ systems].
Mittag M; Haustein UF
Hautarzt; 1998 Jul; 49(7):545-51. PubMed ID: 9715381
[TBL] [Abstract][Full Text] [Related]
55. [Renal involvement in systemic sclerosis].
Guerini S; Cavazzana I; Venturelli C; Rozzi M; Turina S; Sottini L; Tardanico R; Franceschini F; Scolari F
G Ital Nefrol; 2007; 24(4):295-310. PubMed ID: 17659501
[TBL] [Abstract][Full Text] [Related]
56. Systemic Sclerosis Sine Scleroderma in Mexican Patients. Case Reports.
Vera-Lastra O; Sauceda-Casas CA; Domínguez MDPC; Alvarez SAM; Sepulceda-Delgado J
Reumatol Clin (Engl Ed); 2018; 14(4):230-232. PubMed ID: 28065485
[TBL] [Abstract][Full Text] [Related]
57. Drug treatment of scleroderma.
Leighton C
Drugs; 2001; 61(3):419-27. PubMed ID: 11293650
[TBL] [Abstract][Full Text] [Related]
58. Red flags in scleroderma.
Li Q; Sahhar J; Littlejohn G
Aust Fam Physician; 2008 Oct; 37(10):831-4. PubMed ID: 19002303
[TBL] [Abstract][Full Text] [Related]
59. [When thinking to scleroderma?].
Cogan E
Rev Med Brux; 2007 Sep; 28(4):285-9. PubMed ID: 17958022
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
